Due to the limited therapeutic index and the intrinsic toxicity of anticancer drugs, drug reactions in oncology are of special concern. Interactions with other drugs could trigger slight differences in the chemotherapy agent's pharmacokinetics or pharmacodynamic, which may dramatically affect its effectiveness or toxicity. Although precise data is lacking, drug-drug interactions are thought to be more common in oncology than in most other diseases. The identification of potentially clinically important drug reactions has been made possible by advances in in-vitro approaches and early clinical research. Patients with cancer typically take a variety of drugs to control symptoms such as pain and nausea. The types of drug interactions that aris...
In the past decade, many tyrosine-kinase inhibitors have been introduced in oncology and haemato-onc...
In the past decade, many tyrosine-kinase inhibitors have been introduced in oncology and haemato-onc...
Selected classes of medication are presented, and the frequently occurring and/or severe drug intera...
Background: Drug interactions in oncology are of particular importance owing to the narrow therapeut...
It is estimated that almost one-third of adverse reactions to pharmaceutical agents result from drug...
Background: Drug-drug interactions (DDIs) are of major concern in oncology, since cancer patients ty...
Background: Drug-drug interactions (DDIs) are of major concern in oncology, since cancer patients ty...
Objective: The pharmacotherapeutic treatment of patients with cancer is generally associated with mu...
Background and objective Drug interactions are an under-recognized and not much studied issue in onc...
International audienceBACKGROUND: Drug-drug interactions (DDIs) may occur with investigational drugs...
Background: Anticancer drug interactions can affect the efficacy and toxicity of anticancer treatmen...
Drug interactions are common in cancer patients as they use many drugs concurrently. Most drug inter...
Cancer patients often suffer from cancer symptoms, treatment complications and concomitant diseases ...
Background: In this study, it is aimed to explain the type and frequency of potential drug-drug inte...
Targeted therapy drugs, mainly those within the signal transduction inhibitors, are used more chroni...
In the past decade, many tyrosine-kinase inhibitors have been introduced in oncology and haemato-onc...
In the past decade, many tyrosine-kinase inhibitors have been introduced in oncology and haemato-onc...
Selected classes of medication are presented, and the frequently occurring and/or severe drug intera...
Background: Drug interactions in oncology are of particular importance owing to the narrow therapeut...
It is estimated that almost one-third of adverse reactions to pharmaceutical agents result from drug...
Background: Drug-drug interactions (DDIs) are of major concern in oncology, since cancer patients ty...
Background: Drug-drug interactions (DDIs) are of major concern in oncology, since cancer patients ty...
Objective: The pharmacotherapeutic treatment of patients with cancer is generally associated with mu...
Background and objective Drug interactions are an under-recognized and not much studied issue in onc...
International audienceBACKGROUND: Drug-drug interactions (DDIs) may occur with investigational drugs...
Background: Anticancer drug interactions can affect the efficacy and toxicity of anticancer treatmen...
Drug interactions are common in cancer patients as they use many drugs concurrently. Most drug inter...
Cancer patients often suffer from cancer symptoms, treatment complications and concomitant diseases ...
Background: In this study, it is aimed to explain the type and frequency of potential drug-drug inte...
Targeted therapy drugs, mainly those within the signal transduction inhibitors, are used more chroni...
In the past decade, many tyrosine-kinase inhibitors have been introduced in oncology and haemato-onc...
In the past decade, many tyrosine-kinase inhibitors have been introduced in oncology and haemato-onc...
Selected classes of medication are presented, and the frequently occurring and/or severe drug intera...